|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Collisson EA, Campbell JD, Brooks AN,
Berger AH, Lee W, Chmielecki J, Beer DG, Cope L, Creighton CJ,
Danilova L, et al: Cancer Genome Atlas Research Network:
Comprehensive molecular profiling of lung adenocarcinoma. Nature.
511:543–550. 2014. View Article : Google Scholar
|
|
3
|
Ferlay J, Shin H-R, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
4
|
Mehlen P and Puisieux A: Metastasis: A
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar
|
|
5
|
Milkovic L, Siems W, Siems R and Zarkovic
N: Oxidative stress and antioxidants in carcinogenesis and
integrative therapy of cancer. Curr Pharm Des. 20:6529–6542. 2014.
View Article : Google Scholar
|
|
6
|
Wee P and Wang Z: Epidermal growth factor
receptor cell proliferation signaling pathways. Cancers (Basel).
9:3–45. 2017.
|
|
7
|
Milik SN, Lasheen DS, Serya RAT and
Abouzid KAM: How to train your inhibitor: Design strategies to
overcome resistance to Epidermal Growth Factor Receptor inhibitors.
Eur J Med Chem. 7:1–21. 2017.
|
|
8
|
Zhao J, Sun Y, Huang Y, Song F, Huang Z,
Bao Y, Zuo J, Saffen D, Shao Z, Liu W, et al: Functional analysis
reveals that RBM10 mutations contribute to lung adenocarcinoma
pathogenesis by deregulating splicing. Sci Rep. 7:404882017.
View Article : Google Scholar
|
|
9
|
Vinayanuwattikun C, Le Calvez-Kelm F,
Abedi-Ardekani B, Zaridze D, Mukeria A, Voegele C, Vallée M,
Purnomosari D, Forey N, Durand G, et al: Elucidating genomic
characteristics of lung cancer progression from in situ to invasive
adenocarcinoma. Sci Rep. 6:316282016. View Article : Google Scholar
|
|
10
|
Witkiewicz AK, McMillan EA, Balaji U, Baek
G, Lin WC, Mansour J, Mollaee M, Wagner KU, Koduru P, Yopp A, et
al: Whole-exome sequencing of pancreatic cancer defines genetic
diversity and therapeutic targets. Nat Commun. 6:67442015.
View Article : Google Scholar
|
|
11
|
Rintala-Maki ND, Goard CA, Langdon CE,
Wall VE, Traulsen KE, Morin CD, Bonin M and Sutherland LC:
Expression of RBM5-related factors in primary breast tissue. J Cell
Biochem. 100:1440–1458. 2007. View Article : Google Scholar
|
|
12
|
Giannakis M, Mu XJ, Shukla SA, Qian ZR,
Cohen O, Nishihara R, Bahl S, Cao Y, Amin-Mansour A, Yamauchi M, et
al: Genomic correlates of immune-cell infiltrates in colorectal
carcinoma. Cell Reports. 15:857–865. 2016. View Article : Google Scholar
|
|
13
|
Jackson TC, Du L, Janesko-Feldman K, Vagni
VA, Dezfulian C, Poloyac SM, Jackson EK, Clark RS and Kochanek PM:
The nuclear splicing factor RNA binding motif 5 promotes caspase
activation in human neuronal cells, and increases after traumatic
brain injury in mice. J Cereb Blood Flow Metab. 35:655–666. 2015.
View Article : Google Scholar :
|
|
14
|
Loiselle JJ and Sutherland LC:
Differential downregulation of Rbm5 and Rbm10 during skeletal and
cardiac differentiation. In Vitro Cell Dev Biol Anim. 50:331–339.
2014. View Article : Google Scholar
|
|
15
|
Rodor J, FitzPatrick DR, Eyras E and
Cáceres JF: The RNA-binding landscape of RBM10 and its role in
alternative splicing regulation in models of mouse early
development. RNA Biol. 14:45–57. 2017. View Article : Google Scholar
|
|
16
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fulda S: Evasion of apoptosis as a
cellular stress response in cell. Int J Cell Biol. 2:1–6. 2010.
|
|
18
|
Plati J, Bucur O and Khosravi-Far R:
Dysregulation of apoptotic signaling in cancer: Molecular
mechanisms and therapeutic opportunities. J Cell Biochem.
104:1124–1149. 2008. View Article : Google Scholar
|
|
19
|
Goldstraw P, Crowley J, Chansky K, Giroux
DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V and Sobin L;
International Association for the Study of Lung Cancer
International Staging Committee Participating Institutions: The
IASLC Lung Cancer Staging Project: Proposals for the revision of
the TNM stage groupings in the forthcoming (seventh) edition of the
TNM Classification of malignant tumours. J Thorac Oncol. 2:706–714.
2007. View Article : Google Scholar
|
|
20
|
Garrisi VM, Strippoli S, De Summa S, Pinto
R, Perrone A, Guida G, Azzariti A, Guida M and Tommasi S: Proteomic
profile and in silico analysis in metastatic melanoma with and
without BRAF mutation. PLoS One. 9:e1120252014. View Article : Google Scholar
|
|
21
|
Imielinski M, Berger AH, Hammerman PS,
Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M,
Sivachenko A, et al: Mapping the hallmarks of lung adenocarcinoma
with massively parallel sequencing. Cell. 150:1107–1120. 2012.
View Article : Google Scholar
|
|
22
|
Bechara EG, Sebestyén E, Bernardis I,
Eyras E and Valcárcel J: RBM5, 6, and 10 differentially regulate
NUMB alternative splicing to control cancer cell proliferation. Mol
Cell. 52:720–733. 2013. View Article : Google Scholar
|
|
23
|
Wang K, Bacon ML, Tessier JJ, Rintala-Maki
ND, Tang V and Sutherland LC: RBM10 modulates apoptosis and
influences TNF-α gene expression. J Cell Death. 5:1–19. 2012.
View Article : Google Scholar
|
|
24
|
Hernández J, Bechara E, Schlesinger D,
Delgado J, Serrano L and Valcárcel J: Tumor suppressor properties
of the splicing regulatory factor RBM10. RNA Biol. 13:466–472.
2016. View Article : Google Scholar
|
|
25
|
Julie J, Loiselle 1, Justin Roy G and
Leslie C: Sutherland: RBM10 promotes transformation-associated
processes in small cell lung cancer and is directly regulated by
RBM5. PLoS One. 12:1–23. 2017.
|
|
26
|
Tessier SJ, Loiselle JJ, McBain A, Pullen
C, Koenderink BW, Roy JG and Sutherland LC: Insight into the role
of alternative splicing within the RBM10v1 exon 10 tandem donor
site. BMC Res Notes. 8:462015. View Article : Google Scholar
|
|
27
|
Vogelstein B, Lane D and Levine AJ:
Surfing the p53 network. Nature. 408:307–310. 2000. View Article : Google Scholar
|
|
28
|
Martín-Garabato E, Martínez-Arribas F,
Pollán M, Lucas AR, Sánchez J and Schneider J: The small variant of
the apoptosis-associated X-chromosome RBM10 gene is co-expressed
with caspase-3 in breast cancer. Cancer Genomics Proteomics.
5:169–173. 2008.
|
|
29
|
Lo HW, Xia W, Wei Y, Ali-Seyed M, Huang SF
and Hung MC: Novel prognostic value of nuclear epidermal growth
factor receptor in breast cancer. Cancer Res. 65:338–348. 2005.
|
|
30
|
Psyrri A, Yu Z, Weinberger PM, Sasaki C,
Haffty B, Camp R, Rimm D and Burtness BA: Quantitative
determination of nuclear and cytoplasmic epidermal growth factor
receptor expression in oropharyngeal squamous cell cancer by using
automated quantitative analysis. Clin Cancer Res. 11:5856–5862.
2005. View Article : Google Scholar
|
|
31
|
Xiao SJ, Wang LY, Kimura M, Kojima H,
Kunimoto H, Nishiumi F, Yamamoto N, Nishio K, Fujimoto S, Kato T,
et al: S11/RBM10: Multiplicity and cooperativity of nuclear
localisation domains. Biol Cell. 105:162–174. 2013. View Article : Google Scholar
|
|
32
|
Dvinge H, Kim E, Abdel-Wahab O and Bradley
RK: RNA splicing factors as oncoproteins and tumour suppressors.
Nat Rev Cancer. 16:413–430. 2016. View Article : Google Scholar :
|
|
33
|
Inoue A, Yamamoto N, Kimura M, Nishio K,
Yamane H and Nakajima K: RBM10 regulates alternative splicing. FEBS
Lett. 588:942–947. 2014. View Article : Google Scholar
|
|
34
|
Lukong KE, Chang KW, Khandjian EW and
Richard S: RNA-binding proteins in human genetic disease. Trends
Genet. 24:416–425. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ozuemba B, Masilamani TJ, Loiselle JJ,
Koenderink B, Vanderbeck KA, Knee J, Larivière C and Sutherland LC:
Co- and post-transcriptional regulation of Rbm5 and Rbm10 in mouse
cells as evidenced by tissue-specific, developmental and
disease-associated variation of splice variant and protein
expression levels. Gene. 580:26–36. 2016. View Article : Google Scholar
|
|
36
|
Johnston JJ, Sapp JC, Curry C, Horton M,
Leon E, Cusmano-Ozog K, Dobyns WB, Hudgins L, Zackai E and
Biesecker LG: Expansion of the TARP syndrome phenotype associated
with de novo mutations and mosaicism. Am J Med Genet A.
164A:120–128. 2014. View Article : Google Scholar
|
|
37
|
Angeloni D: Molecular analysis of
deletions in human chromosome 3p21 and the role of resident cancer
genes in disease. Brief Funct Genomics Proteomics. 6:19–39. 2007.
View Article : Google Scholar
|
|
38
|
Martínez-Arribas F, Agudo D, Pollán M,
Gómez-Esquer F, Díaz-Gil G, Lucas R and Schneider J: Positive
correlation between the expression of X-chromosome RBM genes (RBMX,
RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer.
J Cell Biochem. 97:1275–1282. 2006. View Article : Google Scholar
|
|
39
|
Sutherland LC: RNA binding motif (RBM)
proteins: A novel family of apoptosis modulators? J Cell Biochem.
94:5–24. 2005. View Article : Google Scholar
|
